93 related articles for article (PubMed ID: 21193465)
1. Thrombospondin 1, fibronectin, and vitronectin are differentially dependent upon RAS, ERK1/2, and p38 for induction of vascular smooth muscle cell chemotaxis.
Willis AI; Sadowitz B; Fuse S; Maier KG; Lee TS; Wang XJ; Tuszynski GP; Sumpio BE; Gahtan V
Vasc Endovascular Surg; 2011 Jan; 45(1):55-62. PubMed ID: 21193465
[TBL] [Abstract][Full Text] [Related]
2. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis.
Willis AI; Fuse S; Wang XJ; Chen E; Tuszynski GP; Sumpio BE; Gahtan V
J Vasc Surg; 2000 Jun; 31(6):1160-7. PubMed ID: 10842153
[TBL] [Abstract][Full Text] [Related]
4. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production.
Lee GL; Chang YW; Wu JY; Wu ML; Wu KK; Yet SF; Kuo CC
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2751-60. PubMed ID: 22995520
[TBL] [Abstract][Full Text] [Related]
5. The effects of nicotine on vascular smooth muscle cell chemotaxis induced by thrombospondin-1 and fibronectin.
Stein JJ; Seymour KA; Maier KG; Gahtan V
Am J Surg; 2011 Nov; 202(5):545-8. PubMed ID: 21944292
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1-induced vascular smooth muscle cell chemotaxis: the role of the type 3 repeat and carboxyl terminal domains.
Lee T; Nesselroth SM; Olson ET; Esemuede N; Lawler J; Sumpio BE; Gahtan V
J Cell Biochem; 2003 Jun; 89(3):500-6. PubMed ID: 12761883
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1-induced migration is functionally dependent upon focal adhesion kinase.
Wang XJ; Maier K; Fuse S; Willis AI; Olson E; Nesselroth S; Sumpio BE; Gahtan V
Vasc Endovascular Surg; 2008; 42(3):256-62. PubMed ID: 18319354
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent.
Gahtan V; Wang XJ; Willis AI; Tuszynski GP; Sumpio BE
Surgery; 1999 Aug; 126(2):203-7. PubMed ID: 10455885
[TBL] [Abstract][Full Text] [Related]
9. Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways.
Campbell M; Allen WE; Sawyer C; Vanhaesebroeck B; Trimble ER
Circ Res; 2004 Aug; 95(4):380-8. PubMed ID: 15242975
[TBL] [Abstract][Full Text] [Related]
10. The role of G proteins in thromospondin-1-induced vascular smooth muscle cell migration.
Fuse S; Esemuede N; Yamaguchi M; Maier KG; Nesselroth SM; Sumpio BE; Gahtan V
Surgery; 2008 Jul; 144(1):86-92. PubMed ID: 18571589
[TBL] [Abstract][Full Text] [Related]
11. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
Sakamoto K; Murata T; Chuma H; Hori M; Ozaki H
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle cell migration induced by domains of thrombospondin-1 is differentially regulated.
Seymour KA; Sadowitz B; Stein JJ; Lawler J; Maier KG; Gahtan V
Am J Surg; 2011 Nov; 202(5):553-7. PubMed ID: 21906719
[TBL] [Abstract][Full Text] [Related]
13. Involvement of MAPKs and NF-kappaB in LPS-induced VCAM-1 expression in human tracheal smooth muscle cells.
Lin WN; Luo SF; Lee CW; Wang CC; Wang JS; Yang CM
Cell Signal; 2007 Jun; 19(6):1258-67. PubMed ID: 17303384
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidemia regulates thrombospondin-1-induced vascular smooth muscle cell chemotaxis.
Desai P; Stein JJ; Siddiqui SA; Maier KG; Gahtan V
Mol Cell Biochem; 2015 Dec; 410(1-2):85-91. PubMed ID: 26350564
[TBL] [Abstract][Full Text] [Related]
15. Breviscapine inhibits high glucose-induced proliferation and migration of cultured vascular smooth muscle cells of rats via suppressing the ERK1/2 MAPK signaling pathway.
He M; Xue ZM; Li J; Zhou BQ
Acta Pharmacol Sin; 2012 May; 33(5):606-14. PubMed ID: 22465949
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional down-regulation of thromboxane A(2) receptor expression via activation of MAPK ERK1/2, p38/NF-kappaB pathways.
Zhang W; Zhang Y; Edvinsson L; Xu CB
J Vasc Res; 2009; 46(2):162-74. PubMed ID: 18769070
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration.
Galaria II; Fegley AJ; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2004 Dec; 122(2):173-9. PubMed ID: 15555614
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-1-induced vascular smooth muscle cell migration is dependent on the hyaluronic acid receptor CD44.
Maier KG; Sadowitz B; Cullen S; Han X; Gahtan V
Am J Surg; 2009 Nov; 198(5):664-9. PubMed ID: 19887196
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells.
McGillicuddy FC; O'Toole D; Hickey JA; Gallagher WM; Dawson KA; Keenan AK
Vascul Pharmacol; 2006 Jun; 44(6):469-75. PubMed ID: 16624629
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM
J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
